Replies to post #429401 on Anavex Life Sciences Corp (AVXL)

[Simonizer]

Interesting to note that every presentation is 30 minutes but the presentation after ours was moved to another day allowing possibly 60 minutes. Coincidence or moved to allow additional time.

[kund]

Daniel Klamer, PhD, MBA, Vice President, Business Development & Scientific Strategy, Anavex Life Sciences Corp.

Anavex Life Sciences Corp.’s lead drug candidate, ANAVEX 2-73, recently completed a successful Phase IIa clinical trial for Alzheimer’s disease. ANAVEX 2-73 is an orally available drug candidate that restores cellular homeostasis by activating the sigma-1 receptor. Full genomic analysis of the study participants resulted in the identification of genetic mutations linked to treatment response. Clinical studies in several indications are planned or underway utilizing a precision medicine approach.

Looks like Anavex team is still on phase2a trial, 2015 data and they are calling it recently completed..

[georgejjl]

Join a breakout discussion group. These are informal, moderated discussions with brainstorming and interactive problem solving, allowing participants from diverse backgrounds to exchange ideas and experiences and develop future collaborations around a focused topic.

Table 7: The Use of Precision Medicine in Drug Development for CNS Disorders
Moderator: Daniel Klamer, PhD, MBA, Vice President, Business Development & Scientific Strategy, Anavex Life Sciences Corp.
What questions should be asked before adding a new biomarker to your clinical trial?
What lessons can we learn from oncology?
Pros and cons using biomarkers as surrogate endpoints

https://www.discoveryontarget.com/CNS-Neurodegenerative-Targets

Good luck and GOD bless,

[Doc328]

September 26, 2018?

[frrol]

Yet another example of you having no clue what you're reading and looking at. Check the dates.

Now say again how you're a "biologist" and making "valid proclamations" with your "scrupulous due diligence".

[falconer66a]

Dates count, do matter. My error.

Is Dr. Klamer risking his professional career?

No, he's not. And this entire post of mine was invalid. I failed to scrutinize and confirm the date of the posted conference. Was a number of years ago; not to happen shortly this year.

Two errors. First by the person who first posted the conference and the presentation by the Anavex officer. Wrong date; wrong year.

Second, by me. Did not authenticate the date and year of the conference.

Therefore, Dr. Klamer's professional standing endures. My date-checking, however, is questionable. Henceforth, I'll strive to be attentive to date-checking in future posts.